Common-Size Income Statement
Quarterly Data
Based on: 10-Q (reporting date: 2026-09-30), 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).
The financial performance over the analyzed period is characterized by a distinct cyclical pattern, with a peak in profitability during 2021 and early 2022, followed by a significant contraction through 2024 and 2025, and a subsequent recovery phase leading into late 2026.
- Gross Profitability and Cost Management
- Gross profit margins exhibited a steady increase from 65.21% in early 2021 to a peak of 70.17% by March 31, 2022. This was followed by a prolonged downward trend, with margins compressing to a low of 55.89% by December 31, 2024. This compression is directly attributed to the rise in the cost of revenue, which climbed from approximately 30% in early 2022 to a peak of 44.11% in late 2024. However, a recovery is evident in 2026, with gross profit margins returning to 64.19% by September 30, 2026, reflecting a reduction in the cost of revenue back to 35.81%.
- Operating Expense Trends
- Research and development (R&D) and selling, general, and administrative (SG&A) expenses both showed a relative increase as a percentage of revenue during the period of margin compression. R&D expenses rose from roughly 8% in 2021 to a peak of 13.06% in March 2023, while SG&A peaked at 12.43% in the same period. This suggests that during periods of declining revenue or margin pressure, these fixed or strategic costs occupied a larger share of total revenue. By late 2026, both metrics normalized, with R&D dropping to 8.75% and SG&A to 7.86%.
- Operating and Net Profitability
- Operating profit margins mirrored the gross profit trend, peaking at 52.25% in early 2022 before declining to a trough of 32.54% in March 2025. The recovery phase saw operating margins climb back to 47.46% by September 30, 2026. Net income followed a similar trajectory, moving from highs of 44.87% in early 2022 to a low of 26.29% in December 2024, eventually recovering to 40.05% by the end of the analyzed period.
- Financial Expenses and Tax Impact
- Interest and debt expenses as a percentage of revenue increased from approximately 1% in 2021 to a peak of 3.43% in June 2022, remaining elevated above 3% for much of 2023 through 2025 before easing to 2.33% by late 2026. Other income and expenses remained relatively low but peaked between 2023 and 2024. The provision for income taxes fluctuated throughout the period, generally ranging between 3% and 7% of revenue, with a notable dip to 2.38% in March 2025.
Overall, the data indicates a high degree of operating leverage, where fluctuations in gross margins significantly impact the bottom line. The transition from 2021 to 2026 demonstrates a full cycle of expansion, contraction, and recovery in both operational efficiency and net profitability.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?